Evidence map›Paper›PMID 41381558›Full record

ArticleScientific reports2025

Multi-response optimization of defined and undefined serum-free media for enhanced proliferation of immortalized lamb muscle cells.

Arian Amirvaresi, Reza Ovissipour

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Arian AmirvaresiDepartment of Food Science and Technology, Texas A&M University, College Station, TX, 77843, USA.
Reza OvissipourDepartment of Food Science and Technology, Texas A&M University, College Station, TX, 77843, USA. ovissi@tamu.edu.

Funding

National Institute of Food and Agriculture 2021-699012-35978
6 · The paper itself

Abstract

The development of serum-free media (SFM) is critical for advancing the scalability and ethical viability of cultivated meat. To our knowledge, this study represents the first systematic, species-specific optimization of serum-free media for immortalized lamb muscle cells (ILMCs), introducing two novel formulations: LM7, a chemically defined medium comprising seven essential components for lamb muscle (LM), and LM8, a chemically undefined medium incorporating eight ingredients. Using design of experiments (DOE), response surface methodology (RSM), we systematically optimized both LM7 and LM8 to maximize ILMC proliferation, preserve cell morphology, and minimize media cost. A custom MATLAB-based image analysis pipeline enabled high-throughput viability classification from cell morphology. Several LM8 formulations achieved proliferation rates statistically comparable to 10% and even 20% fetal bovine serum (FBS). Both LM7 and LM8 sustained ILMC stemness (Pax 7 and Actin) and differentiation potential, as demonstrated by Desmin and myosin heavy chain staining. Finally, both media supported scalable culture in 3D microcarrier systems using CellBIND microcarriers, with significantly better performance observed for LM8 compared to LM7. These findings establish LM7 and LM8 as effective, serum-free platforms for cultivated lamb meat production, enabling both cost-efficiency and regulatory flexibility in cellular agriculture.

Indexed as

Cell Culture TechniquesCell ProliferationMuscle CellsMuscle, SkeletalAnimalsCell DifferentiationCell SurvivalCulture Media, Serum-FreeSheepCulture Media, Serum-FreeCultivated meatLamb muscle cellMedia optimizationRSMSerum-free media

Identifiers

PMID41381558
PMCPMC12698806

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.